PSA updates guidelines for salbutamol, terbutaline inhalers

Pharmacists key to supporting asthma patient to move away from relievers and toward preventers, PSA leader says  Updated treatment guidelines for pharmacists supplying salbutamol and terbutaline inhalers to patients with asthma from the Pharmaceutical Society of Australia (PSA) aim to curb the overreliance on short-acting beta2-agonists (SABA).   Launching the revised guidelines, Dr Fei Sim,